Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John B. Green currently holds 19,421 shares of GTC BIOTHERAPEUTICS INC (GTCB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John B. Green has been a net seller of GTCB stock. They have purchased $20.4K and sold $2.9M worth of shares.
John B. Green's most recent insider trade was on Apr 20, 2020, when they sold 25,624 shares at $22.95 per share.
John B. Green serves as Executive at GTC BIOTHERAPEUTICS INC (GTCB). They have executed 31 insider transactions totaling $2.9M over their tenure at the company.
John B. Green holds the position of Executive at GTC BIOTHERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John B. Green has shown a selling trading pattern, with $20.4K in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John B. Green was on Apr 20, 2020, when they sold $588.1K worth of DRNA shares. This transaction involved 25,624 shares at $22.95 per share.
John B. Green currently owns 19,421 shares of GTC BIOTHERAPEUTICS INC (GTCB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John B. Green's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John B. Green has 31 Form 4 filings on record as an insider at GTC BIOTHERAPEUTICS INC.
Set alerts for John B. Green and 40,000+ other insiders.